NA
Navidea Biopharmaceuticals, Inc.
NAVBQ · OTC
$0.00 -99.75% (-$0.04)
1M +0.00%
Market Cap $10.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.15x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 35.11%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 259.40%
Net margin 23,117.60%
FCF margin 14,282.80%
Quality
57 /100
Average ROIC 280.59%
ROA 347.18%
Asset turnover 0.02x
Debt
50 /100
Moderate Current ratio 0.32x
Int. coverage -12.82x
Net debt/EBITDA -0.03x
Stability
28 /100
Unstable Beta -4.82x
Rev. volatility 1,964.48%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre NAVBQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Craig A. Dais
Employees
11
Headquarters
Dublin
Evenimente viitoare
16 NOV.
Earnings
Upcoming earnings report